Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Szekeres

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Pharmacogenomics|May 11, 2005
Clinical pharmacogenetics of immunosuppressive drugs in organ transplantationThomas Szekeres, Alexander Haushofer
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|July 26, 2002
New targets and drugs in cancer chemotherapyThomas Szekeres, Ladislav Novotny
Hematology (Amsterdam, Netherlands)|May 15, 2003
Cancer therapy: new targets for chemotherapyLadislav Novotny, Thomas Szekeres
Expert Opinion on Therapeutic Targets|June 7, 2005
Recent developments in cancer chemotherapy oriented towards new targetsLadislav Novotny, Thomas Szekeres
Current Medicinal Chemistry|April 23, 2002
Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cellsThomas Szekeres, Jan Sedlak, Ladislav Novotny
Current Medicinal Chemistry|April 23, 2002
Metabolism of the novel IMP dehydrogenase inhibitor benzamide ribosideWalter Jäger, Alexandra Salamon, Thomas Szekeres
Mutation Research|September 25, 2007
Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?Philipp Saiko, Akos Szakmary, Walter Jaeger, et al.
Pharmaceutical Research|March 17, 2010
Resveratrol and resveratrol analogues--structure-activity relationshipThomas Szekeres, Monika Fritzer-Szekeres, Philipp Saiko, et al.
Current Medicinal Chemistry|April 23, 2002
Antitumor activity of benzamide riboside in vitro and in vivoLadislav Novotny, Peter Rauko, Joel A Yalowitz, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2012
Effect of substitution at N″-position of N'-hydroxy-N-amino guanidines on tumor cell growthArijit Basu, Barij Nayan Sinha, Philipp Saiko, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Pharmacogenomics|May 11, 2005
Clinical pharmacogenetics of immunosuppressive drugs in organ transplantationThomas Szekeres, Alexander Haushofer
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|July 26, 2002
New targets and drugs in cancer chemotherapyThomas Szekeres, Ladislav Novotny
Hematology (Amsterdam, Netherlands)|May 15, 2003
Cancer therapy: new targets for chemotherapyLadislav Novotny, Thomas Szekeres
Expert Opinion on Therapeutic Targets|June 7, 2005
Recent developments in cancer chemotherapy oriented towards new targetsLadislav Novotny, Thomas Szekeres
Current Medicinal Chemistry|April 23, 2002
Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cellsThomas Szekeres, Jan Sedlak, Ladislav Novotny
Current Medicinal Chemistry|April 23, 2002
Metabolism of the novel IMP dehydrogenase inhibitor benzamide ribosideWalter Jäger, Alexandra Salamon, Thomas Szekeres
Mutation Research|September 25, 2007
Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?Philipp Saiko, Akos Szakmary, Walter Jaeger, et al.
Pharmaceutical Research|March 17, 2010
Resveratrol and resveratrol analogues--structure-activity relationshipThomas Szekeres, Monika Fritzer-Szekeres, Philipp Saiko, et al.
Current Medicinal Chemistry|April 23, 2002
Antitumor activity of benzamide riboside in vitro and in vivoLadislav Novotny, Peter Rauko, Joel A Yalowitz, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2012
Effect of substitution at N″-position of N'-hydroxy-N-amino guanidines on tumor cell growthArijit Basu, Barij Nayan Sinha, Philipp Saiko, et al.
Pageof 12